KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sleep Number (SNBR) Total Current Liabilities (2016 - 2026)

Sleep Number's Total Current Liabilities history spans 15 years, with the latest figure at $898.8 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 0.53% year-over-year to $898.8 million; the TTM value through Sep 2025 reached $898.8 million, up 0.53%, while the annual FY2024 figure was $908.0 million, 3.0% down from the prior year.
  • Total Current Liabilities for Q3 2025 was $898.8 million at Sleep Number, roughly flat from $903.2 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $945.3 million in Q3 2022 and bottomed at $655.9 million in Q1 2021.
  • The 5-year median for Total Current Liabilities is $906.5 million (2022), against an average of $890.6 million.
  • The largest YoY upside for Total Current Liabilities was 73.81% in 2021 against a maximum downside of 4.74% in 2021.
  • A 5-year view of Total Current Liabilities shows it stood at $890.9 million in 2021, then grew by 4.37% to $929.8 million in 2022, then grew by 0.67% to $936.1 million in 2023, then fell by 3.0% to $908.0 million in 2024, then dropped by 1.01% to $898.8 million in 2025.
  • Per Business Quant, the three most recent readings for SNBR's Total Current Liabilities are $898.8 million (Q3 2025), $903.2 million (Q2 2025), and $904.4 million (Q1 2025).